European Biotech Acquisition Performance
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and European Biotech are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days European Biotech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, European Biotech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
European |
European Biotech Relative Risk vs. Return Landscape
If you would invest (100.00) in European Biotech Acquisition on November 18, 2025 and sell it today you would earn a total of 100.00 from holding European Biotech Acquisition or generate -100.0% return on investment over 90 days. European Biotech Acquisition is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than European, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
European Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of European Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for European Biotech Acq can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| European Biotech Acq is not yet fully synchronised with the market data | |
| European Biotech Acq has some characteristics of a very speculative penny stock | |
| European Biotech Acq has a very high chance of going through financial distress in the upcoming years | |
| European Biotech Acquisition currently holds about 308.1 K in cash with (514.79 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 72.0% of the company shares are held by institutions such as insurance companies |
European Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of European Stock often depends not only on the future outlook of the current and potential European Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. European Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.8 M | |
| Cash And Short Term Investments | 308.5 K |
European Biotech Fundamentals Growth
European Stock prices reflect investors' perceptions of the future prospects and financial health of European Biotech, and European Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on European Stock performance.
| Current Valuation | 164.04 M | |||
| Shares Outstanding | 13.21 M | |||
| Price To Earning | 66.40 X | |||
| Price To Book | 1.34 X | |||
| EBITDA | 342.89 K | |||
| Cash And Equivalents | 308.1 K | |||
| Cash Per Share | 0.02 X | |||
| Book Value Per Share | (0.37) X | |||
| Cash Flow From Operations | (514.79 K) | |||
| Earnings Per Share | 0.02 X | |||
| Total Asset | 129.75 M | |||
Things to note about European Biotech Acq performance evaluation
Checking the ongoing alerts about European Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for European Biotech Acq help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| European Biotech Acq is not yet fully synchronised with the market data | |
| European Biotech Acq has some characteristics of a very speculative penny stock | |
| European Biotech Acq has a very high chance of going through financial distress in the upcoming years | |
| European Biotech Acquisition currently holds about 308.1 K in cash with (514.79 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 72.0% of the company shares are held by institutions such as insurance companies |
- Analyzing European Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether European Biotech's stock is overvalued or undervalued compared to its peers.
- Examining European Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating European Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of European Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of European Biotech's stock. These opinions can provide insight into European Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in European Stock
If you are still planning to invest in European Biotech Acq check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the European Biotech's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |